Accurate and interpretable classification of brain tumors from magnetic resonance imaging (MRI) is critical for effective diagnosis and treatment planning. This study presents an ensemble-based deep learning framework that combines MobileNetV2 and DenseNet121 convolutional neural networks (CNNs) using a soft voting strategy to classify three common brain tumor types: glioma, meningioma, and pituitary adenoma. The models were trained and evaluated on the Figshare dataset using a stratified 5-fold cross-validation protocol. To enhance transparency and clinical trust, the framework integrates an Explainable AI (XAI) module employing Grad-CAM++ for class-specific saliency visualization, alongside a symbolic Clinical Decision Rule Overlay (CDRO) that maps predictions to established radiological heuristics. The ensemble classifier achieved superior performance compared to individual CNNs, with an accuracy of 91.7%, precision of 91.9%, recall of 91.7%, and F1-score of 91.6%. Grad-CAM++ visualizations revealed strong spatial alignment between model attention and expert-annotated tumor regions, supported by Dice coefficients up to 0.88 and IoU scores up to 0.78. Clinical rule activation further validated model predictions in cases with distinct morphological features. A human-centered interpretability assessment involving five board-certified radiologists yielded high Likert-scale scores for both explanation usefulness (mean = 4.4) and heatmap-region correspondence (mean = 4.0), reinforcing the framework's clinical relevance. Overall, the proposed approach offers a robust, interpretable, and generalizable solution for automated brain tumor classification, advancing the integration of deep learning into clinical neurodiagnostics.

Brain tumor occurs due to the abnormal development of cells in the brain. It has adversely affected human health, and early diagnosis is required to improve the survival rate of the patient. Hence, various brain tumor detection models have been developed to detect brain tumors. However, the existing methods often suffer from limited accuracy and inefficient learning architecture. The traditional approaches cannot effectively detect the small and subtle changes in the brain cells. To overcome these limitations, a SpinalNet-Quantum Dilated Convolutional Neural Network (Spinal-QDCNN) model is proposed for detecting brain tumors using MRI images. The Spinal-QDCNN method is developed by the combination of QDCNN and SpinalNet for brain tumor detection using MRI. At first, the input brain image is pre-processed using RoI extraction. Then, image enhancement is done by using the thresholding transformation, which is followed by segmentation using Projective Adversarial Networks (PAN). Then, different processes, like random erasing, flipping, and resizing, are applied in the image augmentation phase. This is followed by feature extraction, where statistical features such as average contrast, kurtosis and skewness, and mean, Gabor wavelet features, Discrete Wavelet Transform (DWT) with Gradient Binary Pattern (GBP) are extracted, and finally detection is done using Spinal-QDCNN. Moreover, the proposed method attained a maximum accuracy of 86.356%, sensitivity of 87.37%, and specificity of 88.357%.

Functional Magnetic Resonance Imaging (fMRI) is an imaging technique widely used to study human brain activity. fMRI signals in areas across the brain transiently synchronise and desynchronise their activity in a highly structured manner, even when an individual is at rest. These functional connectivity dynamics may be related to behaviour and neuropsychiatric disease. To model these dynamics, temporal brain connectivity representations are essential, as they reflect evolving interactions between brain regions and provide insight into transient neural states and network reconfigurations. However, conventional graph neural networks (GNNs) often struggle to capture long-range temporal dependencies in dynamic fMRI data. To address this challenge, we propose BrainATCL, an unsupervised, nonparametric framework for adaptive temporal brain connectivity learning, enabling functional link prediction and age estimation. Our method dynamically adjusts the lookback window for each snapshot based on the rate of newly added edges. Graph sequences are subsequently encoded using a GINE-Mamba2 backbone to learn spatial-temporal representations of dynamic functional connectivity in resting-state fMRI data of 1,000 participants from the Human Connectome Project. To further improve spatial modeling, we incorporate brain structure and function-informed edge attributes, i.e., the left/right hemispheric identity and subnetwork membership of brain regions, enabling the model to capture biologically meaningful topological patterns. We evaluate our BrainATCL on two tasks: functional link prediction and age estimation. The experimental results demonstrate superior performance and strong generalization, including in cross-session prediction scenarios.

Accurate, noninvasive detection of isocitrate dehydrogenase (IDH) mutation is essential for effective glioma management. Traditional methods rely on invasive tissue sampling, which may fail to capture a tumor's spatial heterogeneity. While deep learning models have shown promise in molecular profiling, their performance is often limited by scarce annotated data. In contrast, foundation deep learning models offer a more generalizable approach for glioma imaging biomarkers. We propose a Foundation-based Biomarker Network (FoundBioNet) that utilizes a SWIN-UNETR-based architecture to noninvasively predict IDH mutation status from multi-parametric MRI. Two key modules are incorporated: Tumor-Aware Feature Encoding (TAFE) for extracting multi-scale, tumor-focused features, and Cross-Modality Differential (CMD) for highlighting subtle T2-FLAIR mismatch signals associated with IDH mutation. The model was trained and validated on a diverse, multi-center cohort of 1705 glioma patients from six public datasets. Our model achieved AUCs of 90.58%, 88.08%, 65.41%, and 80.31% on independent test sets from EGD, TCGA, Ivy GAP, RHUH, and UPenn, consistently outperforming baseline approaches (p <= 0.05). Ablation studies confirmed that both the TAFE and CMD modules are essential for improving predictive accuracy. By integrating large-scale pretraining and task-specific fine-tuning, FoundBioNet enables generalizable glioma characterization. This approach enhances diagnostic accuracy and interpretability, with the potential to enable more personalized patient care.

Anxiety is a common yet often underdiagnosed and undertreated comorbidity in multiple sclerosis (MS). While altered fear processing is a hallmark of anxiety in other populations, its neurobehavioral mechanisms in MS remain poorly understood. This study investigates the extent to which neurobehavioral mechanisms of fear generalization contribute to anxiety in MS. We recruited 18 persons with MS (PwMS) and anxiety, 36 PwMS without anxiety, and 23 healthy persons (HPs). Participants completed a functional MRI (fMRI) fear generalization task to assess fear processing and diffusion-weighted MRI for graph-based structural connectome analyses. Consistent with findings in non-MS anxiety populations, PwMS with anxiety exhibit fear overgeneralization, perceiving non-threating stimuli as threatening. A machine learning model trained on HPs in a multivariate pattern analysis (MVPA) cross-decoding approach accurately predicts behavioral fear generalization in both MS groups using whole-brain fMRI fear response patterns. Regional fMRI prediction and graph-based structural connectivity analyses reveal that fear response activity and structural network integrity of partially overlapping areas, such as hippocampus (for fear stimulus comparison) and anterior insula (for fear excitation), are crucial for MS fear generalization. Reduced network integrity in such regions is a direct indicator of MS anxiety. Our findings demonstrate that MS anxiety is substantially characterized by fear overgeneralization. The fact that a machine learning model trained to associate fMRI fear response patterns with fear ratings in HPs predicts fear ratings from fMRI data across MS groups using an MVPA cross-decoding approach suggests that generic fear processing mechanisms substantially contribute to anxiety in MS.

Accurate segmentation of femur structures from Magnetic Resonance Imaging (MRI) is critical for orthopedic diagnosis and surgical planning but remains challenging due to the limitations of existing 2D and 3D deep learning-based segmentation approaches. In this study, we propose XAG-Net, a novel 2.5D U-Net-based architecture that incorporates pixel-wise cross-slice attention (CSA) and skip attention gating (AG) mechanisms to enhance inter-slice contextual modeling and intra-slice feature refinement. Unlike previous CSA-based models, XAG-Net applies pixel-wise softmax attention across adjacent slices at each spatial location for fine-grained inter-slice modeling. Extensive evaluations demonstrate that XAG-Net surpasses baseline 2D, 2.5D, and 3D U-Net models in femur segmentation accuracy while maintaining computational efficiency. Ablation studies further validate the critical role of the CSA and AG modules, establishing XAG-Net as a promising framework for efficient and accurate femur MRI segmentation.

CNS cancers are complex, difficult-to-treat malignancies that remain insufficiently understood and mostly incurable, despite decades of research efforts. Artificial intelligence (AI) is poised to reshape neuro-oncological practice and research, driving advances in medical image analysis, neuro-molecular-genetic characterisation, biomarker discovery, therapeutic target identification, tailored management strategies, and neurorehabilitation. This Review examines key opportunities and challenges associated with AI applications along the neuro-oncological care trajectory. We highlight emerging trends in foundation models, biophysical modelling, synthetic data, and drug development and discuss regulatory, operational, and ethical hurdles across data, translation, and implementation gaps. Near-term clinical translation depends on scaling validated AI solutions for well defined clinical tasks. In contrast, more experimental AI solutions offer broader potential but require technical refinement and resolution of data and regulatory challenges. Addressing both general and neuro-oncology-specific issues is essential to unlock the full potential of AI and ensure its responsible, effective, and needs-based integration into neuro-oncological practice.

To treat Trochlear Dysplasia (TD), current approaches rely mainly on low-resolution clinical Magnetic Resonance (MR) scans and surgical intuition. The surgeries are planned based on surgeons experience, have limited adoption of minimally invasive techniques, and lead to inconsistent outcomes. We propose a pipeline that generates super-resolved, patient-specific 3D pseudo-healthy target morphologies from conventional clinical MR scans. First, we compute an isotropic super-resolved MR volume using an Implicit Neural Representation (INR). Next, we segment femur, tibia, patella, and fibula with a multi-label custom-trained network. Finally, we train a Wavelet Diffusion Model (WDM) to generate pseudo-healthy target morphologies of the trochlear region. In contrast to prior work producing pseudo-healthy low-resolution 3D MR images, our approach enables the generation of sub-millimeter resolved 3D shapes compatible for pre- and intraoperative use. These can serve as preoperative blueprints for reshaping the femoral groove while preserving the native patella articulation. Furthermore, and in contrast to other work, we do not require a CT for our pipeline - reducing the amount of radiation. We evaluated our approach on 25 TD patients and could show that our target morphologies significantly improve the sulcus angle (SA) and trochlear groove depth (TGD). The code and interactive visualization are available at https://wehrlimi.github.io/sr-3d-planning/.

Large Language Models (LLMs) offer a promising solution for extracting structured clinical information from free-text radiology reports. The Simplified Magnetic Resonance Index of Activity (sMARIA) is a validated scoring system used to quantify Crohn's disease (CD) activity based on Magnetic Resonance Enterography (MRE) findings. This study aims to evaluate the performance of two advanced LLMs in extracting key imaging features and computing sMARIA scores from free-text MRE reports. This retrospective study included 117 anonymized free-text MRE reports from patients with confirmed CD. ChatGPT (GPT-4o) and DeepSeek (DeepSeek-R1) were prompted using a structured input designed to extract four key radiologic features relevant to sMARIA: bowel wall thickness, mural edema, perienteric fat stranding, and ulceration. LLM outputs were evaluated against radiologist annotations at both the segment and feature levels. Segment-level agreement was assessed using accuracy, mean absolute error (MAE) and Pearson correlation. Feature-level performance was evaluated using sensitivity, specificity, precision, and F1-score. Errors including confabulations were recorded descriptively. ChatGPT achieved a segment-level accuracy of 98.6%, MAE of 0.17, and Pearson correlation of 0.99. DeepSeek achieved 97.3% accuracy, MAE of 0.51, and correlation of 0.96. At the feature level, ChatGPT yielded an F1-score of 98.8% (precision 97.8%, sensitivity 99.9%), while DeepSeek achieved 97.9% (precision 96.0%, sensitivity 99.8%). LLMs demonstrate near-human accuracy in extracting structured information and computing sMARIA scores from free-text MRE reports. This enables automated assessment of CD activity without altering current reporting workflows, supporting longitudinal monitoring and large-scale research. Integration into clinical decision support systems may be feasible in the future, provided appropriate human oversight and validation are ensured.

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that severely impairs cognitive function and quality of life. Timely intervention in AD relies heavily on early and precise diagnosis, which remains challenging due to the complex and subtle structural changes in the brain. Most existing deep learning methods focus only on a single plane of structural magnetic resonance imaging (sMRI) and struggle to accurately capture the complex and nonlinear relationships among pathological regions of the brain, thus limiting their ability to precisely identify atrophic features. To overcome these limitations, we propose an innovative framework, MPF-KANSC, which integrates multi-plane fusion (MPF) for combining features from the coronal, sagittal, and axial planes, and a Kolmogorov-Arnold Network-guided spatial-channel attention mechanism (KANSC) to more effectively learn and represent sMRI atrophy features. Specifically, the proposed model enables parallel feature extraction from multiple anatomical planes, thus capturing more comprehensive structural information. The KANSC attention mechanism further leverages a more flexible and accurate nonlinear function approximation technique, facilitating precise identification and localization of disease-related abnormalities. Experiments on the ADNI dataset confirm that the proposed MPF-KANSC achieves superior performance in AD diagnosis. Moreover, our findings provide new evidence of right-lateralized asymmetry in subcortical structural changes during AD progression, highlighting the model's promising interpretability.